Kritische 8-K Meldungen
| Datum | Meldung | Schwere | Filing | Auszug |
|---|---|---|---|---|
| 16.12.2025 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | a) of the Exchange Act. ☐ Item 5.02. Departure of Directors or Principal Officers; Election of Directors; Appointmen |
| 28.03.2024 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | 3(a) of the Exchange Act. ☐ Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment o |
| 22.02.2024 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | 3(a) of the Exchange Act. ☐ Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment o |
| 19.12.2023 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | ection 13(a) of the Exchange Act. ☐ Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appoi |
| 30.01.2023 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | 13(a) of the Exchange Act. ☐ Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointmen |
Stammdaten
Myomo, Inc., a wearable medical robotics company, designs, develops, and produces myoelectric orthotics for people with neuromuscular disorders in the United States. The company offers MyoPro, a myoelectric-controlled upper limb brace or orthosis product used for supporting a patient's weak or paralyzed arm to enable and improve functional activities of daily living. Its products are designed to help improve function in adults and adolescents with neuromuscular conditions due to brachial plexus injury, stroke, traumatic brain injury, spinal cord injury, and other neurological disorders. The company sells its products to orthotics and prosthetics providers, the Veterans Health Administration, and rehabilitation hospitals, as well as through distributors. Myomo, Inc. was incorporated in 2004 and is headquartered in Boston, Massachusetts.
Unternehmen & Branche
| Name | MYOMO, INC. |
|---|---|
| Ticker | MYO |
| CIK | 0001369290 |
| Boerse | US |
| Sektor | Healthcare |
| Industrie | Medical - Devices |
| SIC | 3842 · Orthopedic, Prosthetic & Surgical Appliances & Supplies |
Wertpapier & Kennzahlen
| CUSIP | – |
|---|---|
| ISIN | – |
| Typ | Common Stock |
| Marktkapitalisierung | 31,6 Mio. USD |
| Beta | 1,16 |
| Dividendenrendite | 0,00 % |
Externe Quellen: SEC EDGAR » · FMP-Profil » · Yahoo Finance »
Finanzkennzahlen (SEC XBRL)
| Periode | Filing | Umsatz | Nettoergebnis | EPS | Aktiva | Eigenkapital |
|---|---|---|---|---|---|---|
| 2025-12-31 | 10-K | 40,928,042 | -15,573,884 | -0.37 | 38,636,573 | 11,403,467 |
| 2025-09-30 | 10-Q | 10,090,699 | -3,662,915 | -0.09 | 34,077,430 | 14,625,583 |
| 2025-06-30 | 10-Q | 9,652,234 | -4,631,972 | -0.11 | 38,672,347 | 17,615,128 |
| 2025-03-31 | 10-Q | 9,831,814 | -3,465,058 | -0.08 | 40,867,327 | 21,687,064 |
| 2024-12-31 | 10-K | 32,551,199 | -6,183,729 | -0.16 | 42,244,079 | 24,714,057 |
| 2024-09-30 | 10-Q | 9,207,586 | -966,409 | -0.03 | 16,312,871 | 9,292,334 |
| 2024-06-30 | 10-Q | 7,520,767 | -1,121,607 | -0.03 | 16,190,381 | 9,677,711 |
| 2024-03-31 | 10-Q | 3,754,389 | -3,835,632 | -0.10 | 16,520,857 | 10,899,757 |
| 2023-12-31 | 10-K | 19,241,158 | -8,147,565 | -0.28 | 14,581,568 | 8,989,350 |
| 2023-09-30 | 10-Q | 5,079,523 | -2,029,016 | -0.06 | 17,053,965 | 11,023,111 |
| 2023-06-30 | 10-Q | 5,958,544 | -1,014,150 | -0.04 | 13,296,992 | 8,820,032 |
| 2023-03-31 | 10-Q | 3,446,708 | -2,644,295 | -0.11 | 13,736,159 | 9,631,991 |
| 2022-12-31 | 10-K | 15,555,229 | -10,721,022 | -1.52 | 10,162,006 | 6,359,365 |
| 2022-09-30 | 10-Q | 3,968,201 | -2,829,716 | -0.40 | 12,157,006 | 7,821,896 |
| 2022-08-16 | 10-K | 1,000,000,000 | ||||
| 2022-06-30 | 10-Q | 3,677,575 | -2,908,922 | -0.42 | 14,561,503 | 10,347,596 |
| 2022-03-31 | 10-Q | 3,867,926 | -2,814,934 | -0.41 | 17,976,640 | 12,869,712 |
| 2021-12-31 | 10-K | 13,856,374 | -10,372,329 | -1.89 | 20,095,412 | 15,409,131 |
| 2021-09-30 | 10-Q | 4,383,957 | -2,057,022 | -0.36 | 17,459,184 | 13,147,546 |
| 2021-06-30 | 10-Q | 3,104,294 | -2,621,315 | -0.46 | 17,708,666 | 13,811,289 |
Fondsaktivität (Vorquartalsvergleich)
Insider-Transaktionen (12 Monate)
| Datum | Insider | Rolle | Typ | Stückzahl | Kurs | Wert (USD) | Δ | Trend |
|---|---|---|---|---|---|---|---|---|
| 2026-03-16 | Getz Heather C | Director | Open Market Purchase | 20,000 | 0.70 | 13,972.00 | +29,0% | |
| 2026-03-13 | KIRK THOMAS F | Director | Open Market Purchase | 72,000 | 0.71 | 51,112.80 | +106,1% | |
| 2026-03-12 | Getz Heather C | Director | Open Market Purchase | 70,000 | 0.73 | 50,960.00 | +105,8% | |
| 2025-11-21 | KIRK THOMAS F | Director | Open Market Purchase | 2,535 | 0.72 | 1,825.20 | +3,8% | |
| 2025-11-20 | KIRK THOMAS F | Director | Open Market Purchase | 4,902 | 0.72 | 3,529.44 | +7,3% | |
| 2025-11-19 | Crowley Thomas Aloysius Jr. | Director | Open Market Purchase | 385 | 0.77 | 294.53 | +0,6% | |
| 2025-11-18 | Crowley Thomas Aloysius Jr. | Director | Open Market Purchase | 4,000 | 0.73 | 2,938.00 | +6,1% | |
| 2025-08-25 | KIRK THOMAS F | Director | Open Market Purchase | 50,000 | 1.15 | 57,500.00 | +119,3% | |
| 2025-08-18 | KIRK THOMAS F | Director | Open Market Purchase | 50,000 | 1.10 | 55,000.00 | +114,2% | |
| 2025-08-15 | GUDONIS PAUL R | Director, Officer, Chief Executive Officer | Open Market Purchase | 50,000 | 0.95 | 47,295.00 | +98,2% | |
| 2025-05-15 | GUDONIS PAUL R | Director, Officer, Chief Executive Officer | Open Market Purchase | 30,000 | 3.22 | 96,612.00 | +200,5% | |
| 2025-05-15 | KIRK THOMAS F | Director | Open Market Purchase | 36,824 | 3.25 | 119,678.00 | +248,4% | |
| 2025-05-14 | KIRK THOMAS F | Director | Open Market Purchase | 1,943 | 3.25 | 6,314.75 | +13,1% | |
| 2025-05-12 | KIRK THOMAS F | Director | Open Market Purchase | 50,000 | 3.35 | 167,500.00 | +347,6% |
Top-Fondshalter
Keine Fondsdaten zu dieser Aktie vorhanden.